Latest Quarter
Q1 FY2026ended 2026-03-31 · filed 2026-05-06
$1.6B
$39.85M
N/A
$0.28
$609.69M
$5.25B
$1.34B
$1.07B
What this quarter tells us
In Q1 FY2026 (ended March 31, 2026), Ardent Health reported revenue of $1.602 billion, up 7.0% year-over-year. Net income was $39.85 million, a decline of 3.7% from the prior year. Diluted EPS was $0.28, down 3.4% year-over-year. The company held $609.7 million in cash, $1.337 billion in equity, and $1.073 billion in long-term debt.
- •Revenue increased 7.0% YoY to $1.602 billion.
- •Net income decreased 3.7% YoY to $39.85 million.
- •Diluted EPS fell 3.4% to $0.28.
- •Cash and equivalents stood at $609.7 million; long-term debt was $1.073 billion.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.